Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.

Published in:

Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.974364

By:

• Ghaemi, Amir;
• Asl, Parisa Roshani;
• Zargaran, Hedieh;
• Ahmadi, Delaram;
• Hashimi, Asim Ali;
• Abdolalipour, Elahe;
• Bathaeian, Sahar;
• Miri, Seyed Mohammad

Publication type:

Article